Lactose (India)

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE058I01013
  • NSEID:
  • BSEID: 524202
INR
103.95
-0.2 (-0.19%)
BSENSE

Jun 23, 02:20 PM

BSE+NSE Vol: 3.44 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Lactose (India)
Smruthi Organic
Tyche Industries
Bal Pharma
Godavari Drugs
Alpa Laboratorie
Sotac Pharma.
Kimia Bioscien.
Pharmaids Pharma
Balaxi Pharma
Krebs Biochem

Why is Lactose (India) Ltd ?

1
Healthy long term growth as Net Sales has grown by an annual rate of 36.10% and Operating profit at 45.23%
2
Positive results in Mar 26
  • NET SALES(9M) At Rs 123.72 cr has Grown at 42.31%
  • PAT(9M) At Rs 4.57 cr has Grown at 58.13%
  • PBT LESS OI(Q) At Rs 2.09 cr has Grown at 64.6% (vs previous 4Q average)
3
With ROCE of 9.5, it has a Attractive valuation with a 1.5 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 3.43%, its profits have risen by 17.6% ; the PEG ratio of the company is 0.7
4
26.07% of Promoter Shares are Pledged
  • In falling markets, high promoter pledged shares puts additional downward pressure on the stock prices
5
Market Beating performance in long term as well as near term
  • Along with generating 3.43% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Lactose (India) should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Lactose (India) for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Lactose (India)
3.43%
0.06
53.60%
Sensex
-6.56%
-0.49
13.24%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
36.10%
EBIT Growth (5y)
45.23%
EBIT to Interest (avg)
1.91
Debt to EBITDA (avg)
3.66
Net Debt to Equity (avg)
0.95
Sales to Capital Employed (avg)
0.89
Tax Ratio
29.70%
Dividend Payout Ratio
0
Pledged Shares
26.07%
Institutional Holding
0.62%
ROCE (avg)
9.96%
ROE (avg)
8.52%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
22
Industry P/E
34
Price to Book Value
2.02
EV to EBIT
15.96
EV to EBITDA
10.82
EV to Capital Employed
1.52
EV to Sales
1.18
PEG Ratio
0.68
Dividend Yield
NA
ROCE (Latest)
9.55%
ROE (Latest)
9.37%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

20What is working for the Company
NET SALES(9M)

At Rs 123.72 cr has Grown at 42.31%

PAT(9M)

At Rs 4.57 cr has Grown at 58.13%

PBT LESS OI(Q)

At Rs 2.09 cr has Grown at 64.6% (vs previous 4Q average

-2What is not working for the Company
INTEREST(Latest six months)

At Rs 2.82 cr has Grown at 24.78%

Loading Valuation Snapshot...

Here's what is working for Lactose (India)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 2.09 cr has Grown at 64.6% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 1.27 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 1.88 cr has Grown at 55.7% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 1.21 Cr
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
Highest at Rs 45.77 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Net Sales - Quarterly
At Rs 45.77 cr has Grown at 26.0% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 36.33 Cr
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Here's what is not working for Lactose (India)

Interest - Latest six months
At Rs 2.82 cr has Grown at 24.78%
over previous Half yearly period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)